CIEL Healthcare

2

COUNTRIES

3

HOSPITALS

20

PRIMARY AND SECONDARY CARE CLINICS

3

MAIN CENTRAL LABORATORIES

32

C-LAB COLLECTION CENTRES

2,170

EMPLOYEES
CLUSTER REVENUE

MUR 3,562M

2021: MUR 2,995M

EBITDA

MUR 817M

2021: MUR 557M


PROFIT AFTER TAX

MUR 432M

2021: MUR 296M

MARKET DYNAMICS
AND OUTLOOK

Hélène Echevin

Chief Executive Officer of C-Care Limited discusses performance and operating context.

PERFORMANCE & STRATEGY

  • Progress Report for FY22 Priorities for FY23
    • Consolidate C-Care brand equity
    • Finalise rebranding and new communication strategy

  • Progress Report for FY22 Priorities for FY23
    • C-Care Darné renovation

    • Oncology unit project started

    • Start of construction of the new C-Care Clinic in Grand Baie

    • Accelerate digital journey and leverage business intelligence tools to drive efficiencies

    • Continue to focus on patient care and quality across operations

    • Continue to improve clinical and non-clinical procedures in view of Comprehensive Health Knowledge System (CHKS)

    • CHKS certification in progress for C-Care

    • Launched nursing school in partnership with Charles Telfair Institute

    • Quality strategy: Comprehensive Health Knowledge System (CHKS) Accreditation obtained

    • C-Care App: Launch

    • C-Lab: Increase number of collection centres

    • C-Care Darné renovation of levels, maternity ward and new wellness centre and oncology unit

    • C-Care Grand Baie: Work in Progess

    • C-Care Tamarin: Relocalisation

  • Progress Report for FY22 Priorities for FY23
    • Successful re-branding

    • Revamping of hospital

    • Revamping of Jinja Clinic

    • Drive occupancy and asset utilisation

    • Launch of C-Lab Uganda: In-house laboratory operations

    • Successful exit from insurance business

    • Continue to increase volumes and asset utilisation e.g. CT scan

    • C-Care IHK: Maternity ward renovation

    • C-Care Clinic: Renovations and relocations

  • Progress Report for FY22 Priorities for FY23
    • The Ugandan market continues to benefit from its newly launched laboratory activities under C-Lab Uganda

    • Uganda: Opening of eight new collection centres

    • Mauritius: continue to grow the C-Lab footprint

ESG COMMITMENTS

CARBON ACCOUNTING AND MANAGEMENT TOOL PROJECT

The project consists in assessing the carbon footprint of C-Care (International) Ltd. The full assessment will be carried out in March 2023 by an external organisation.

ACT FOR YOUR COMMUNITY

Our CSR framework is being finalised and will be completed end of 2022. It aims to support vulnerable groups of people in our community, with a specific attention to adults and children suffering from diabetes (the main non-communicable disease in Mauritius).

Our goal is to give back to the community and democratise access to quality healthcare through free screening services and engaging NGOs on training programmes.

IDENTIFIED RISKS AND MITIGATION

STRATEGIC

• New entrants in the market

• Lack of clinical staff (nurses)

• Purchasing power caused by high inflation

FINANCIAL

• Risk of recession affecting revenue

• Inflation increasing cost base and not being able to pass this on to customers

OPERATIONAL

• Recruiting and retaining talents

COMPLIANCE – HEALTH & SAFETY
• Risk of data breaches

OUR ASSOCIATED GROUP PRINCIPAL RISKS SHOW HOW WE MANAGE RISKS AND FIND OPPORTUNITIES